skip to content

Cambridge Immunology Network

 
Read more at: GSK Discovery Partnership with Academia Fast Track Golden Triangle Challenge - call open External Call for proposals

GSK Discovery Partnership with Academia Fast Track Golden Triangle Challenge - call open External Call for proposals

22 October 2016

This new Call for Proposals has a closing date of 28th October 2016. Key Questions that need to be considered before applying are: 1) Do you have a clear therapeutic hypothesis? 2) Do you have a defined drug target? 3) Do you have enabling expertise?


Read more at: 60 YEARS OF THE BRITISH SOCIETY FOR IMMUNOLOGY

60 YEARS OF THE BRITISH SOCIETY FOR IMMUNOLOGY

11 October 2016

The British Society for Immunology celebrates 60 years on Tuesday 11 October. We are proud to have supported immunology and immunologists during this time and we hope as many of you as possible are able to join us in celebrating this important milestone.


Read more at: Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its developmental pathway

Single-cell RNA-seq identifies a PD-1hi ILC progenitor and defines its developmental pathway

29 September 2016

Yong Yu, Jason C.H. Tsang, Cui Wang, Simon Clare, Juexuan Wang, Xi Chen, Cordelia Brandt, Leanne Kane, Lia S. Campos, Liming Lu, Gabrielle T. Belz, Andrew N. J. McKenzie, Sarah A. Teichmann, Gordon Dougan & Pentao Liu


Read more at: Huge £114million research investment announced for Cambridge- BRC

Huge £114million research investment announced for Cambridge- BRC

14 September 2016

Cambridge is set to get a huge £114m from the Government to make world-first medical breakthroughs, as part of a record package of research funding announced today by Health Secretary Jeremy Hunt.


Read more at: Imagine a world without borders: an immunologist’s thoughts on Brexit

Imagine a world without borders: an immunologist’s thoughts on Brexit

17 August 2016

Francesco Colucci shares his thoughts on Brexit


Read more at: Call for EMI collaborative research projects with AstraZeneca/MedImmune

Call for EMI collaborative research projects with AstraZeneca/MedImmune

17 August 2016

The Experimental Medicine Training Initiative (EMI) is an exciting scheme recently set up between University of Cambridge, Cambridge University Hospitals NHS Trust, NIHR Cambridge Biomedical Research Centre, and Pharmaceutical Industry partners interested in developing scientific expertise in the field of experimental medicine (Clinical Trials).


Read more at: Case study on Department of Veterinary Medicine research informing WHO guidelines

Case study on Department of Veterinary Medicine research informing WHO guidelines

6 July 2016

Dr Caroline Trotter and her team at Cambridge’s Department of Veterinary Medicine have used mathematical modelling to help ensure that World Health Organisation guidelines provide the most robust and effective approach to meningitis vaccinations in Sub-Saharan Africa.


Read more at: Public Engagement Seed Fund

Public Engagement Seed Fund

15 June 2016

The Public Engagement team is pleased to launch a new and exciting opportunity that gives University of Cambridge researchers the chance to apply for small grants to undertake innovative, research-focused public engagement activities.


Read more at: Call for collaborative research proposals with GlaxoSmithKline

Call for collaborative research proposals with GlaxoSmithKline

15 June 2016

The University of Cambridge/ CUH/ GSK Joint Steering Committee (JSC) are pleased to announce a new call for collaborative Cambridge/GSK research proposals. This is the fourth annual call under the “Varsity” initiative which has to date funded 12 new collaborative medicine-focused projects. More information about the initiative can be found here.


Read more at: 2016 EUROPEAN PATENT OFFICE INVENTOR AWARD

2016 EUROPEAN PATENT OFFICE INVENTOR AWARD

23 May 2016

Helen Lee (Haematology) was selected from 470 nominations by the European Patent Office to be one of the 3 finalists for SAMBA, the technology she and her group have developed. They have greatly simplified the detection of infectious diseases by nucleic acid amplification suitable for resource-poor settings.